Skip to main content
SpringerLink
Log in

Peripartum Cardiomyopathy

  • Chapter
  • First Online:
Congestive Heart Failure and Cardiac Transplantation

  • 2940 Accesses

Abstract

Peripartum cardiomyopathy is a serious, life-threatening disease. An increasingly recognized cause of pregnancy-related maternal mortality, prognosis is highly variable and difficult to predict. Risk factors and incidence vary widely worldwide. Incidence in the United States ranges from 1:1141 to 1:4350 live births, but it ranges from 1:1000 in South Africa to 1:300 in Haiti. About 45 % of cases are identified within 1 week of delivery and 75 % of cases within 1 month. Risk factors range from maternal age > 30 years to the African race, hypertension, multiparity, pregnancy with multiple fetuses, maternal cocaine use, and oral tocolytic therapy. This chapter describes the etiology and clinical presentation of peripartum cardiomyopathy, differential diagnosis, and treatment options. Acute management focuses on oxygenation and hemodynamic support—comparable to managing heart failure during pregnancy. Cardiogenic shock may require vasodilator and inotropic therapy. Some patients require cardiac transplantation. Chronic management includes pharmacological treatment similar to treating idiopathic dilated cardiomyopathy. Data are limited regarding use of defibrillators and cardiac resynchronization therapy, but implanted medical devices pose risks and have no proven clinical benefit. Emerging therapies are very promising but require testing via prospective, double-blinded study to understand their impact on morbidity and mortality. One therapy showing potential is bromocriptine; in one small study, it enabled greater recovery of left ventricular ejection fraction compared to the standard of care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nadel AS, Ballermann BJ, Anderson S, Brenner BM. Interrelationships among atrial peptides, renin, and blood volume in pregnant rats. Am J Physiol. 1988;254(5 Pt 2):R793–800.

    CAS  PubMed  Google Scholar 

  2. Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Sodium and diuretics in pregnancy. N Engl J Med. 1984;311(10):617–22.

    Article  CAS  PubMed  Google Scholar 

  3. Lund CJ, Donovan JC. Blood volume during pregnancy: significance of plasma and red cell volumes. Am J Obstet Gynecol. 1967;98(3):394–403.

    Article  CAS  PubMed  Google Scholar 

  4. Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology. 1965;26:393–9.

    Article  CAS  PubMed  Google Scholar 

  5. Milman N, Graudal N, Nielsen OJ, Agger AO. Serum erythropoietin during normal pregnancy: relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women. Int J Hematol. 1997;66(2):159–68.

    Article  CAS  PubMed  Google Scholar 

  6. Bader RA, Bader ME, Rose DF, Braunwald E. Hemodynamics at rest and during exercise in normal pregnancy as studied by cardiac catheterization. J Clin Invest. 1955;34(10):1524–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ueland K, Novy MJ, Peterson EN, Metcalfe J. Maternal cardiovascular dynamics. IV. The influence of gestational age on the maternal cardiovascular response to posture and exercise. Am J Obstet Gynecol. 1969;104(6):856–64.

    Article  CAS  PubMed  Google Scholar 

  8. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256(4 Pt 2):H1060–5.

    CAS  PubMed  Google Scholar 

  9. Burwell CS. The placenta as a modified arteriovenous fistula, considered in relation to the circulatory adjustments to pregnancy. Am J Med Sci. 1938;195:1–7. doi:10.1016/S0002-9378(38)91025-7.

    Article  Google Scholar 

  10. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 1996;175(6):1668–74. doi:10.1016/S0002-9378(96)70123-0.

    Article  CAS  PubMed  Google Scholar 

  11. Weiner CP, Thompson LP. Nitric oxide and pregnancy. Semin Perinatol. 1997;21(5):367–80. doi:10.1016/S0146-0005(97)80003-1.

    Article  CAS  PubMed  Google Scholar 

  12. Edouard DA, Pannier BM, London GM, Cuche JL, Safar ME. Venous and arterial behavior during normal pregnancy. Am J Physiol. 1998;274(5 Pt 2):H1605–12.

    CAS  PubMed  Google Scholar 

  13. Ayala DE, Hermida RC, Mojón A, Fernandez JR, Silva I, Ucieda R, Iglesias M. Blood pressure variability during gestation in healthy and complicated pregnancies. Hypertension. 1997;30(3 Pt 2):611–8.

    Article  CAS  PubMed  Google Scholar 

  14. Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP, Peeters LH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993;169(6):1382–92.

    Article  CAS  PubMed  Google Scholar 

  15. Manalo-Estrella P, Barker AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol. 1967;83(4):336–41.

    CAS  PubMed  Google Scholar 

  16. Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol. 1997;177(1):162–9. doi:10.1016/S0002-9378(97)70456-3.

    Article  CAS  PubMed  Google Scholar 

  17. Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest. 1981;12(3):141–54.

    Article  CAS  PubMed  Google Scholar 

  18. Prisco D, Ciuti G, Falciani M. Hemostatic changes in normal pregnancy. haematologica reports. 2005;1(10):1-5.

    Google Scholar 

  19. Kjeldsen J. Hemodynamic investigations during labour and delivery. Acta Obstet Gynecol Scand Suppl. 1979;89:1–252.

    CAS  PubMed  Google Scholar 

  20. Ueland K, Hansen J. Maternal cardiovascular dynamics. II. Posture and uterine contractions. Am J Obstet Gynecol. 1969;103(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  21. Robson SC, Dunlop W, Boys RJ, Hunter S. Cardiac output during labour. Br Med J (Clin Res Ed). 1987;295(6607):1169–72. doi:10.1136/bmj.295.6607.1169.

    Article  CAS  Google Scholar 

  22. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9):1183–8. doi:10.1097/00132586-200012000-00016.

    Article  CAS  PubMed  Google Scholar 

  23. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270–6. doi:10.1093/eurheartj/ehm342.

    Article  PubMed  Google Scholar 

  24. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16. doi:10.1161/circulationaha.106.174287.

    Article  PubMed  Google Scholar 

  25. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ, Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–78. doi:10.1093/eurjhf/hfq120.

    Article  PubMed  Google Scholar 

  26. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–5. doi:10.1161/01.CIR.0000162478.36652.7E.

    Article  PubMed  Google Scholar 

  27. Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011;118(3):583–91. doi:10.1097/AOG.0b013e318229e6de.

    Article  PubMed  Google Scholar 

  28. Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–4. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed8&NEWS=N&AN=2007331974.

    Article  PubMed  Google Scholar 

  29. Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97(12):1765–8. doi:10.1016/j.amjcard.2006.01.039.

    Article  PubMed  Google Scholar 

  30. Harper MA, Meyer RE, Berg CJ. Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality. Obstet Gynecol. 2012;120(5):1013–9. doi:10.1097/AOG.0b013e3182805f53.

    PubMed  Google Scholar 

  31. Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105(6):1303–8. doi:10.1097/01.AOG.0000161382.30233.ba.

    Article  PubMed  Google Scholar 

  32. Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol. 1997;176(1 Pt 1):182–8. doi:10.1016/S0002-9378(97)80033-6.

    Article  CAS  PubMed  Google Scholar 

  33. Desai D, Moodley J, Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct. 1995;25(3):118–23. doi:10.1177/004947559502500310.

    Article  CAS  PubMed  Google Scholar 

  34. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80(12):1602–6. doi:10.4065/80.12.1602.

    Article  PubMed  Google Scholar 

  35. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Jain D, Gass A, Ahmed A, Panza JA, Fonarow GC. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3(3):e001056. doi:10.1161/JAHA.114.001056.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, Gunnar RM. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6):1053–61. doi:10.1161/01.CIR.44.6.1053.

    Article  CAS  PubMed  Google Scholar 

  37. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol. 2010;55(7):654–9. doi:10.1016/j.jacc.2009.09.043.

    Article  PubMed  Google Scholar 

  38. Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31. doi:10.1016/j.ijcard.2010.08.065.

    Article  PubMed  Google Scholar 

  39. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152(3):509–13. doi:10.1016/j.ahj.2006.02.008.

    Article  PubMed  Google Scholar 

  40. Roberts JM, Pearson G, Cutler J, Lindheimer M, NHLBI Working Group on Research on Hypertension During Pregnancy. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertension. 2003;41(3):437–45. doi:10.1161/01.HYP.0000054981.03589.E9.

    Article  CAS  PubMed  Google Scholar 

  41. Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, Khatri N, Elkayam U. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17(5):426–30. doi:10.1016/j.cardfail.2011.01.007.

    Article  PubMed  Google Scholar 

  42. Russell RB, Petrini JR, Damus K, Mattison DR, Schwarz RH. The changing epidemiology of multiple births in the United States. Obstet Gynecol. 2003;101(1):129–35. doi:10.1016/S0029-7844(02)02316-5.

    PubMed  Google Scholar 

  43. Mendelson MA, Chandler J. Postpartum cardiomyopathy associated with maternal cocaine abuse. Am J Cardiol. 1992;70(11):1092–4.

    Article  CAS  PubMed  Google Scholar 

  44. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589–600. doi:10.1016/j.cell.2006.12.036.

    Article  CAS  PubMed  Google Scholar 

  45. Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A, Martial JA, Hilfiker-Kleiner D, Struman I. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 2013;123(5):2143–54. doi:10.1172/JCI64365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27(4):441–6. doi:10.1093/eurheartj/ehi481.

    Article  CAS  PubMed  Google Scholar 

  47. Habedank D, Kühnle Y, Elgeti T, Dudenhausen JW, Haverkamp W, Dietz R. Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail. 2008;10(11):1149–51. doi:10.1016/j.ejheart.2008.09.001.

    Article  CAS  PubMed  Google Scholar 

  48. Hilfiker-Kleiner D, Meyer GP, Schieffer E, Goldmann B, Podewski E, Struman I, Fischer P, Drexler H. Recovery From postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol. 2007;50(24):2354–5. doi:10.1016/j.jacc.2007.10.006.

    Article  PubMed  Google Scholar 

  49. Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G. Peripartum cardiomyopathy-a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol. 2008;199(4):e5–6. doi:10.1016/j.ajog.2008.06.051.

    Article  PubMed  Google Scholar 

  50. Meyer GP, Labidi S, Podewski E, Sliwa K, Drexler H, Hilfiker-Kleiner D. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J Med Case Rep. 2010;4:80. doi:10.1186/1752-1947-4-80.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Hilfiker-Kleiner D. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465–73. doi:10.1161/CIRCULATIONAHA.109.901496.

    Article  CAS  PubMed  Google Scholar 

  52. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, Yip A, Klein G, Sliwa K. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10(9):861–8. doi:10.1016/j.ejheart.2008.07.005.

    Article  CAS  PubMed  Google Scholar 

  53. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35(3):701–5. doi:10.1016/s0735-1097(99)00624-5.

    Article  CAS  PubMed  Google Scholar 

  54. Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2002;4(3):305–9.

    Article  CAS  PubMed  Google Scholar 

  55. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333–8. doi:10.1038/nature11040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Nelson JL. Pregnancy, persistent microchimerism, and autoimmune disease. J Am Med Womens Assoc. 1998;53(1):31–2. 47.

    CAS  Google Scholar 

  57. Sundstrom JB, Fett JD, Carraway RD, Ansari AA. Is peripartum cardiomyopathy an organ-specific autoimmune disease? Autoimmun Rev. 2002;1(1-2):73–7. doi:10.1016/S1568-9972(01)00009-X.

    Article  PubMed  Google Scholar 

  58. Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol. 2007;118(1):14–20. doi:10.1016/j.ijcard.2006.04.090.

    Article  PubMed  Google Scholar 

  59. Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom B, Arif G, Essop R, Ansari A, Fett J, Yacoub M. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J. 2005;150(2):263–9. doi:10.1016/j.ahj.2004.09.008.

    Article  CAS  PubMed  Google Scholar 

  60. Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol. 2002;23(3):301–24. doi:10.1385/CRIAI:23:3:301.

    Article  CAS  PubMed  Google Scholar 

  61. Cénac A, Beaufils H, Soumana I, Vetter JM, Devillechabrolle A, Moulias R. Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. Int J Cardiol. 1990;26(1):49–52. doi:10.1016/0167-5273(90)90246-2.

    Article  PubMed  Google Scholar 

  62. Melvin K, Richardson P, Olsen E, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 1982;307(12):731–4.

    Article  CAS  PubMed  Google Scholar 

  63. Sanderson JE, Olsen EG, Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J. 1986;56(3):285–91. doi:10.1136/hrt.56.3.285.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005;193(2):363–5. doi:10.1016/j.ajog.2005.01.022.

    Article  PubMed  CAS  Google Scholar 

  65. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation. 1990;81(3):922–8. doi:10.1161/01.CIR.81.3.922.

    Article  CAS  PubMed  Google Scholar 

  66. Pierce JA, Price BO, Joyce JW. Familial occurrence of postpartal heart failure. Arch Intern Med. 1963;111:651–5.

    Article  CAS  PubMed  Google Scholar 

  67. Fett JD, Sundstrom BJ, Etta King M, Ansari AA. Mother-daughter peripartum cardiomyopathy. Int J Cardiol. 2002;86(2-3):331–2.

    Article  PubMed  Google Scholar 

  68. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995;129(2):421–2.

    Article  CAS  PubMed  Google Scholar 

  69. Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation. 2010;121(20):2176–82. doi:10.1161/CIRCULATIONAHA.109.931220.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010;121(20):2169–75. doi:10.1161/CIRCULATIONAHA.109.929646.

    Article  PubMed  Google Scholar 

  71. Groesdonk HV, Dinse-Lambracht A, Doblanzki W, Doblanzki U, Galm C, Muth C-M. Unrecognized peripartum cardiomyopathy: case series and comprehensive review of the literature. Appl Cardiopulm Pathophysiol. 2009;13(3):237–42.

    Google Scholar 

  72. Diao M, Diop IB, Kane A, Camara S, Kane A, Sarr M, Ba SA, Diouf SM. Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. [Article in French]. Arch Mal Coeur Vaiss. 2004;97(1):25–30.

    CAS  PubMed  Google Scholar 

  73. Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol. 1997;177(5):1129–32. doi:10.1016/S0002-9378(97)80722-3.

    Article  CAS  PubMed  Google Scholar 

  74. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94(2):311–6. doi:10.1016/S0029-7844(99)00293-8.

    CAS  PubMed  Google Scholar 

  75. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol. 1992;69(17):1458–66.

    Article  CAS  PubMed  Google Scholar 

  76. Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–67.

    Article  CAS  PubMed  Google Scholar 

  77. Webb JA, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15(6):1234–40. doi:10.1007/s00330-004-2583-y.

    Article  PubMed  Google Scholar 

  78. Expert Panel on MR Safety, Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley Jr WG, Froelich JW, Gimbel JR, Gosbee JW, Kuhni-Kaminski E, Larson PA, Lester Jr JW, Nyenhuis J, Schaefer DJ, Sebek EA, Weinreb J, Wilkoff BL, Woods TO, Lucey L, Hernandez D. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37(3):501–30. doi:10.1002/jmri.24011.

    Article  Google Scholar 

  79. MRI Contrast Agents and Breast Feeding Mothers. MRISafety.com. [Internet]. Accessed on 2016 May 116. Available from: www.mrisafety.com/SafetyInfov.asp?s_keyword=lactation&s_Anywords=&SafetyInfoID=246.

  80. European Society of Gynecology (ESG). 2011. Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97. doi:10.1093/eurheartj/ehr218.

    Article  Google Scholar 

  81. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239. doi:10.1016/j.jacc.2013.05.019.

    Article  PubMed  Google Scholar 

  82. Brantigan CO, Grow JB, Schoonmaker FW. Extended use of intra-aortic balloon pumping in peripartum cardiomyopathy. Ann Surg. 1976;183(1):1–4. doi:10.1097/00000658-197601000-00001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Gevaert S, Van Belleghem Y, Bouchez S, Herck I, De Somer F, De Block Y, Tromp F, Vandecasteele E, Martens F, De Pauw M. Acute and critically ill peripartum cardiomyopathy and ‘bridge to’ therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15(2):R93. doi:10.1186/cc10098.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Tandler R, Schmid C, Weyand M, Scheld HH. Novacor LVAD bridge to transplantation in peripartum cardiomyopathy. Eur J Cardiothoracic Surg. 1997;11(2):394–6. doi:10.1016/S1010-7940(96)01066-4.

    Article  CAS  Google Scholar 

  85. Lewis R, Mabie W, Burlew B, Sibai B. Biventricular assist device as a bridge to cardiac transplantation in the treatment of peripartum cardiomyopathy. South Med J. 1997;90(9):955–8.

    Article  CAS  PubMed  Google Scholar 

  86. Oosterom L, de Jonge N, Kirkels J, Klöpping C, Lahpor J. Left ventricular assist device as a bridge to recovery in a young woman admitted with peripartum cardiomyopathy. Neth Heart J. 2008;16(12):426–8. doi:10.1007/BF03086192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Zimmerman H, Bose R, Smith R, Copeland JG. Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. Ann Thorac Surg. 2010;89(4):1211–7. doi:10.1016/j.athoracsur.2009.12.064.

    Article  PubMed  Google Scholar 

  88. Zimmerman H, Coelho-Anderson R, Smith R, Nolan P, Copeland J. Bridge to recovery with a Thoratec biventricular assist device for postpartum cardiomyopathy. ASAIO J. 2010;56(5):479–80.

    Article  PubMed  Google Scholar 

  89. Yang HS, Hong YS, Rim SJ, Yu SH. Extracorporeal membrane oxygenation in a patient with peripartum cardiomyopathy. Ann Thorac Surg. 2007;84(1):262–4. doi:10.1016/j.athoracsur.2007.02.050.

    Article  PubMed  Google Scholar 

  90. Aziz TM, Burgess MI, Acladious NN, Campbell CS, Rahman AN, Yonan N, Deiraniya AK. Heart transplantation for peripartum cardiomyopathy: a report of three cases and a literature review. Cardiovasc Surg. 1999;7(5):565–7.

    Article  CAS  PubMed  Google Scholar 

  91. Rickenbacher PR, Rizeq MN, Hunt SA, Billingham ME, Fowler MB. Long-term outcome after heart transplantation for peripartum cardiomyopathy. Am Heart J. 1994;127(5):1318–23.

    Article  CAS  PubMed  Google Scholar 

  92. Keogh A, Macdonald P, Spratt P, Marshman D, Larbalestier R, Kaan A. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transpl. 1994;13(2):202–7.

    CAS  Google Scholar 

  93. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–84. doi:10.1056/NEJM200004133421502.

    Article  CAS  PubMed  Google Scholar 

  94. Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G, Folsom JW, Silber DH, Kirklin JK, Cardiac Transplant Research Database Group. Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis. J Heart Lung Transplant. 2007;26(11):1097–104. doi:10.1016/j.healun.2007.08.002.

    Article  PubMed  Google Scholar 

  95. Saltzberg MT, Szymkiewicz S, Bianco NR. Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail. 2012;18(1):21–7. doi:10.1016/j.cardfail.2011.09.004.

    Article  PubMed  Google Scholar 

  96. Hopp L, Haider B, Iffy L. Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement. Int J Cardiol. 1996;57(3):227–32. doi:10.1016/S0167-5273(96)02789-1.

    Article  CAS  PubMed  Google Scholar 

  97. Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am J Obstet Gynecol. 2009;201(2):171.e1–5. doi:10.1016/j.ajog.2009.04.037.

    Article  Google Scholar 

  98. Sliwa K, Forster O, Tibazarwa K, Libhaber E, Becker A, Yip A, Hilfiker-Kleiner D. Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus. Int J Cardiol. 2011;147(2):202–8. doi:10.1016/j.ijcard.2009.08.022.

    Article  PubMed  Google Scholar 

  99. Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol. 2002;186(5):1005–10. doi:10.1067/mob.2002.122423.

    Article  PubMed  Google Scholar 

  100. Carvalho A, Brandao A, Martinez EE, et al. Prognosis in peripartum cardiomyopathy. Am J Cardiol. 1989;64(8):540–2. doi:10.1097/00006254-199003000-00010.

    Article  CAS  PubMed  Google Scholar 

  101. Duran N, Günes H, Duran I, Biteker M, Özkan M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet. 2008;101(2):137–40. doi:10.1016/j.ijgo.2007.11.007.

    Article  PubMed  Google Scholar 

  102. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, Hameed A, Gviazda I, Shotan A. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med. 2001;344(21):1567–71 [Erratum in N Engl J Med. 2001;345(7):552].

    Article  CAS  PubMed  Google Scholar 

  103. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15(8):645–50. doi:10.1016/j.cardfail.2009.03.008.

    Article  PubMed  Google Scholar 

  104. Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol. 2003;102(6):1326–31. doi:10.1016/j.obstetgynecol.2003.08.009.

    PubMed  Google Scholar 

  105. Habli M, O’Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008;199(4):415.e1–5. doi:10.1016/j.ajog.2008.06.087.

    Article  Google Scholar 

  106. Mandal D, Mandal S, Mukherjee D, Biswas SC, Maiti TK, Chattopadhaya N, Majumdar B, Panja M. Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res. 2011;37(3):222–7. doi:10.1111/j.1447-0756.2010.01378.x.

    Article  PubMed  Google Scholar 

  107. Fett JD, Fristoe KL, Welsh SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet. 2010;109(1):34–6. doi:10.1016/j.ijgo.2009.10.011.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lillehei Heart Institute, Department of Medicine, University of Minnesota Medical Center, University of Minnesota, 2231, 6th Street SE, 4-146 Cancer and Cardiovascular Research Building, Minneapolis, MN, 55455, USA

    Alan Berger & Daniel J. Garry MD, PhD

Authors
  1. Alan Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J. Garry MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel J. Garry MD, PhD .

Editor information

Editors and Affiliations

  1. Lillehei Heart Institute, Department of Medicine, University of Minnesota Medical Center, University of Minnesota, Minneapolis, Minnesota, USA

    Daniel J. Garry

  2. Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, Minnesota, USA

    Robert F. Wilson

  3. Division of Cardiovascular Medicine, University of Minnesota, Minneapolis, Minnesota, USA

    Zeev Vlodaver

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Berger, A., Garry, D.J. (2017). Peripartum Cardiomyopathy. In: Garry, D., Wilson, R., Vlodaver, Z. (eds) Congestive Heart Failure and Cardiac Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-44577-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44577-9_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44575-5

  • Online ISBN: 978-3-319-44577-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation